Seattle Heart Failure Model (SHFM) Calculator

Clinical calculation support · Verify results before clinical use

Patient characteristics

Enter clinical, laboratory, medication, and device data to estimate survival in chronic heart failure.

—Model

Clinical characteristics

Laboratory values

Conversion used: furosemide 80 mg = torsemide 40 mg = bumetanide 3 mg.

Current medications

Implanted devices

Select one device category only. Device effects are represented using the original model's hazard ratios; this simplified implementation does not reproduce all eligibility rules or later SHFM updates.
—SHFM score*
Estimated survival
Complete the inputs
Predictions are displayed after calculation. This implementation requires independent validation before clinical use.
1-year survival—estimated
2-year survival—estimated
3-year survival—estimated

*The displayed score is the model's linear predictor based on the implemented coefficients; it should not be used as a cohort-validation SHFMScore without confirming exact variable coding and calibration.

About the Seattle Heart Failure Model

The Seattle Heart Failure Model (SHFM) is a multivariable prognostic model developed to estimate survival in patients with heart failure using clinical characteristics, laboratory measurements, medications, and implanted devices.

The original model was derived in 1,125 patients and prospectively validated in five additional cohorts totaling 9,942 patients. Its predictions are estimates for populations similar to those used in model development and validation; calibration may differ in contemporary practice and other populations.

Inputs included

  • Age, sex, NYHA class, LVEF, ischemic etiology, systolic blood pressure, and weight.
  • Sodium, total cholesterol, hemoglobin, lymphocyte percentage, uric acid, and loop diuretic dose.
  • Selected heart-failure medications and device status.

Interpretation

Survival percentages are model-based estimates, not individual certainties. Do not use this calculator alone to determine treatment, device implantation, advanced therapies, or goals of care. The implementation below uses published hazard-ratio transformations and the original exponential baseline survival equation; it has not been independently validated against the official SHFM calculator.

References

Levy WC, Mozaffarian D, Linker DT, et al.The Seattle Heart Failure Model: prediction of survival in heart failure. Circulation. 2006;113(11):1424–1433. DOI: 10.1161/CIRCULATIONAHA.105.584102.
https://doi.org/10.1161/CIRCULATIONAHA.105.584102
University of Washington — Seattle Heart Failure ModelOfficial model overview and description of derivation and validation cohorts.
Official SHFM overview
University of Washington — SHFM updatesDocumentation of subsequent model updates and interpretation cautions.
Official SHFM updates
Clinical disclaimer: For educational and decision-support purposes only. This is an independent implementation and is not affiliated with or endorsed by the University of Washington. It has not undergone external clinical validation or regulatory assessment. Verify estimates with the official model and current clinical context before making patient-care decisions.